Cetera Investment Advisers
OVID icon

Cetera Investment Advisers’s Ovid Therapeutics OVID Stock Holding History

Cetera Investment Advisers’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.7K Sell
17,000
-1
-0% -$2 ﹤0.01% 4614
2025
Q4 		$27.7K Buy
17,001
+1
+0% +$2 ﹤0.01% 4558
2025
Q3 		$22.1K Buy
+17,000
New +$14.7K ﹤0.01% 4485
2021
Q2 		– Sell
-17,954
Closed -$72K – 1815
2021
Q1 		$72K Buy
+17,954
New +$59.6K ﹤0.01% 1570

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cetera Investment Advisers's OVID Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Ovid Therapeutics (OVID) stake by 0.01% in Q1 2026, selling an estimated $2 and leaving 17,000 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4614.

Cetera Investment Advisers first reported a position in OVID in Q1 2021 and has held it in 4 quarters since. The position peaked at $72K in Q1 2021. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Cetera Investment Advisers held 17,000 shares of Ovid Therapeutics worth $37.7K as of Q1 2026.
  • Cetera Investment Advisers sold 1 Ovid Therapeutics share in Q1 2026, an estimated $2.
  • Ovid Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4614 holding.
  • Cetera Investment Advisers first reported a position in Ovid Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Ovid Therapeutics position peaked at $72K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.